JPS6239593A - Rroduction of phospholipid containing substantially no cholesterol - Google Patents

Rroduction of phospholipid containing substantially no cholesterol

Info

Publication number
JPS6239593A
JPS6239593A JP17906385A JP17906385A JPS6239593A JP S6239593 A JPS6239593 A JP S6239593A JP 17906385 A JP17906385 A JP 17906385A JP 17906385 A JP17906385 A JP 17906385A JP S6239593 A JPS6239593 A JP S6239593A
Authority
JP
Japan
Prior art keywords
cholesterol
phospholipid
silica gel
purified
phospholipids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP17906385A
Other languages
Japanese (ja)
Inventor
Yasuhiko Shigematsu
康彦 重松
Mineo Hasegawa
峯夫 長谷川
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kewpie Corp
Original Assignee
QP Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by QP Corp filed Critical QP Corp
Priority to JP17906385A priority Critical patent/JPS6239593A/en
Publication of JPS6239593A publication Critical patent/JPS6239593A/en
Pending legal-status Critical Current

Links

Abstract

PURPOSE:To readily obtain the titled phospholipid useful for such as an emulsifier for midicine, by dissolving a purified phospholipid containing cholesterol in a non-polar solvent, containing the resulting solution with a silica gel and removing the silica gell and the solvent. CONSTITUTION:A purified phospholipid containing cholesterol [preferably one compound of <= about 5wt% cholesterol, <= about 5wt% triglyceride and >=90wt% phospholipid] is dissolved in a non-polar solvent (example; n-hexane, etc.) at the concentration of preferably a 0.1-30wt%. Then silica gel is added thereinto and dispersed while stirring to adsorb the cholesterol, then the silica gel is removed by, for example, filtration and the solvent is distilled off under reduced pressure to obtain the aimed phospholipid usually containing <= about 0.1wt% cholesterol. The amount of silica gel to be used is more than 5 times that of the cholesterol contained therein.

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明はコレステロールを実質上含まない燐脂質を製造
する新規な方法に関するものである。
DETAILED DESCRIPTION OF THE INVENTION [Industrial Field of Application] The present invention relates to a novel method for producing phospholipids that are substantially free of cholesterol.

〔従来の技術〕[Conventional technology]

精製燐脂質は医薬品用乳化剤やリポソーム形成剤などと
して特に医薬の分野で従来より利用されている。このよ
うな利用に対する合目的的な立場から精製燐脂質は燐脂
質以外の成分、例えばコレ。
Purified phospholipids have traditionally been used particularly in the pharmaceutical field as pharmaceutical emulsifiers and liposome forming agents. Purified phospholipids are made from ingredients other than phospholipids, such as these, from a purposeful standpoint for such use.

ステロールなど、の含有量はできるだけ少ないものが望
ましいとされている。
It is desirable that the content of sterols and the like be as low as possible.

精製燐脂質は従来より、例えば、粗製燐脂質をアセトン
処理して中性脂質を除去するなどの溶剤による精製法に
より得ている。
Purified phospholipids have conventionally been obtained by purification methods using solvents, such as treating crude phospholipids with acetone to remove neutral lipids.

〔発明が解決しようとする問題点〕[Problem that the invention seeks to solve]

しかしこのJ:うな溶剤による精製法ではその操作は簡
単であっても得られる精製燐脂質は含有コレステロール
の残存量が約0.5〜5%程度と高いものであった(本
発明において%はすべて車間%である)。燐脂質中の含
有コレステロールを除去するには、例えばカラムクロマ
トグラフィーや液体クロマトグラフィーなどを利用する
こともできそれなりの効果も期待しうるが、このような
方法では、高価な装置、資材などを要するために最11
製品のコスト高を招いてしまう。
However, in this J:Una solvent purification method, although the operation was simple, the purified phospholipid obtained had a high residual amount of cholesterol of about 0.5 to 5% (in the present invention, % is (All figures are in percent between cars). To remove the cholesterol contained in phospholipids, for example, column chromatography or liquid chromatography can be used and can be expected to be somewhat effective, but such methods require expensive equipment and materials. up to 11
This results in higher product costs.

よって、本発明は簡易な精製法であって、しかも燐脂質
の医学分野での利用拡大を計りうるコレステロールを実
質上歯まない燐脂質の新規な製法を提供することを目的
とする。
Therefore, an object of the present invention is to provide a novel method for producing phospholipids that is simple and substantially free of cholesterol, which can expand the use of phospholipids in the medical field.

〔問題点を解決するための手段〕[Means for solving problems]

本発明者らは上記の目的に即して鋭意研究を重ねた結果
、従来法により既に精製しであるコレステロール含有燐
脂質を非極性溶媒に溶解させたのちシリカゲルに接触さ
せるならばこのシリカゲルは燐脂質の組成を変えること
なくコルステロールのみを選択的に吸着除去することを
見い出した。
As a result of extensive research in accordance with the above objective, the present inventors have found that if a cholesterol-containing phospholipid that has already been purified by a conventional method is dissolved in a nonpolar solvent and then brought into contact with silica gel, this silica gel will become phosphorous. We have discovered that only cholesterol can be selectively adsorbed and removed without changing the lipid composition.

従来、非極性溶媒とシリカゲルとを組み合わせた精製法
としては、例えば特開昭48−12304号公報で開示
せる粗製鶏卵脂質からこの組み合わせ法を利用して不快
臭を除く方法が知られている。精製の対象である粗製鶏
卵脂質中には中性脂質が多色に含まれており(油脂62
%、ステリン類5%、燐脂質33%)、よって上記方法
を利用してこのものを精製すると中性脂質の、例えばト
リグリセリドなどが優先的に吸着除去されるためか不快
臭は低減されてもこの方法においてはコレステロールの
除去はほとんど期待できないものであった。このように
従来の非極性溶媒とシリカゲルとの組み合わせを利用し
た精製法はコレステロールの除去に対してのこの方法の
有用性については何ら示唆するものではなかった。
Conventionally, as a purification method using a combination of a nonpolar solvent and silica gel, there has been known a method for removing unpleasant odors from crude egg lipid using this combination method, for example, as disclosed in Japanese Patent Application Laid-open No. 12304/1983. The crude egg lipid that is the target of purification contains neutral lipids in many colors (fats and oils 62
%, sterins: 5%, phospholipids: 33%).Therefore, when this product is purified using the above method, neutral lipids such as triglycerides are preferentially adsorbed and removed, although the unpleasant odor is reduced. This method could hardly be expected to remove cholesterol. As described above, the conventional purification method using a combination of a nonpolar solvent and silica gel did not suggest anything about the usefulness of this method for removing cholesterol.

本発明者らはコレステロールを実質上歯まない燐脂質の
新規な製法の開発に際して上記の非極性溶媒とシリカゲ
ルとの組み合わせ精製法の利用可能性に関して12急研
究を重ねた結果、意外にも前)ホしたように、従来法に
従って一旦精製してa3 <ならばその精製燐脂質中の
コレステロールをこの組み合わせ精製法によってほぼ完
全に除去することができることを見い出して本発明を完
成するに至った。
In developing a new method for producing phospholipids that are virtually free of cholesterol, the present inventors conducted 12 rapid studies on the possibility of using the above-mentioned purification method in combination with a non-polar solvent and silica gel, and found that they were able to ) As mentioned above, we have completed the present invention by discovering that if a3 < is obtained by once purifying according to the conventional method, cholesterol in the purified phospholipid can be almost completely removed by this combined purification method.

本発明は、コレステロールを含有せる精製燐脂質を非極
性溶媒に溶解させ、得られた溶液をシリカゲルに接触さ
せた模このシリカゲルを除去し、次いでこの溶°液から
上記非極性溶媒を留去することを特徴とするコレステロ
ールを実質上歯まない燐脂質の製法を提供するものであ
る。
The present invention involves dissolving purified phospholipids containing cholesterol in a non-polar solvent, contacting the resulting solution with silica gel, removing the silica gel, and then distilling off the non-polar solvent from this solution. The present invention provides a method for producing phospholipids that are substantially free of cholesterol.

本発明の方法が適用される原料燐脂質は従来のいずれか
の精製法により精製された燐脂質であってしかもコレス
テロールを含有せるものである。
The raw material phospholipid to which the method of the present invention is applied is a phospholipid purified by any conventional purification method and contains cholesterol.

従来の精製法による精製燐脂質はコレステロール残存量
が通常0.5〜5%程度であることから、本発明の方法
の精製燐脂質原料はコレステロール含量が約5%以下の
ものであるといえる。本発明の方法の精製燐ffi質原
料は、また、後述せる試験例の結果より明らかなように
、トリグリセリド含量が多いと本発明の方法のコレステ
ロール除去効果が得難いことからこのトリグリセリド含
量が約5%以下にまで精製されており、よって燐脂質が
約90%以上にまで精製されているものが好ましい。
Since purified phospholipids obtained by conventional purification methods usually have a residual amount of cholesterol of about 0.5 to 5%, it can be said that the purified phospholipid raw material used in the method of the present invention has a cholesterol content of about 5% or less. The purified phosphorus ffi raw material used in the method of the present invention also has a triglyceride content of approximately 5%, since it is difficult to obtain the cholesterol removal effect of the method of the present invention when the triglyceride content is high, as is clear from the results of the test examples described below. Therefore, it is preferable that the phospholipid is purified to about 90% or more.

このような精製燐脂質としては、例えば、卵黄、動物の
脳組織、魚卵などからエタノール、ジクロロメタン、n
−ヘキサン、エーテルなどの溶媒を用いて抽出したもの
(粗製燐脂質)を更にアセトン処理して中性脂質を除去
して得たものなどが挙げられる。
Such purified phospholipids include, for example, egg yolk, animal brain tissue, fish eggs, etc., ethanol, dichloromethane, n
- Examples include those obtained by extracting with a solvent such as hexane or ether (crude phospholipids) and further treating with acetone to remove neutral lipids.

本発明の方法において用いる精製燐脂質の溶剤は非極性
溶媒であり、例えばn−ペンタン、n−ヘキサン、n−
へブタンなどC〜C1oの飽和炭化水素を挙げることが
できる。後)水の試験例の結果より明らかなように、エ
タノールやジクロロメタンなどの極性溶媒ではコレステ
ロール除去効果はmMい。非極性溶媒中の精製燐脂質の
濃度は、即ち得られる溶液中におけるこの精製燐脂質の
濃度は0.1〜30%程度であるのが好ましい。
The solvent for purified phospholipid used in the method of the invention is a nonpolar solvent, such as n-pentane, n-hexane, n-
Mention may be made of C to C1o saturated hydrocarbons such as hebutane. (2) As is clear from the results of the water test, polar solvents such as ethanol and dichloromethane have a negligible cholesterol removal effect. The concentration of the purified phospholipid in the nonpolar solvent, ie, the concentration of the purified phospholipid in the resulting solution, is preferably about 0.1 to 30%.

0.1%未満では溶剤量が多すぎて経済的でなく、また
30%を越すと粘度が増加するために精製操作に困難が
伴うようになるからである。
If it is less than 0.1%, the amount of solvent is too large and is not economical, and if it exceeds 30%, the viscosity increases, making purification operations difficult.

本発明の方法において用いるシリカゲルは特に限定的な
ものでなく、例えば市販の薄層クロマトグラフィー用ま
たはカラムクロマトグラフィー用のシリカゲルをそのま
ま用いてもよく、あるいはそれを80〜130℃で30
分〜3時間程度活性化処理したものであってもよい。シ
リカゲルの使用出は残存せるコレステロールの吊に対し
て通常5倍量以上用いるとよい。使用但が5倍母より少
ないと充分なコレステロール除去効果が[いからである
The silica gel used in the method of the present invention is not particularly limited, and for example, commercially available silica gel for thin layer chromatography or column chromatography may be used as is, or it may be heated for 30 minutes at 80 to 130°C.
It may be activated for about minutes to 3 hours. The amount of silica gel to be used is usually at least 5 times the amount of remaining cholesterol. If the amount used is 5 times less than that of the mother, sufficient cholesterol removal effect will be obtained.

Ii[Q脂質の溶液とシリカゲルとの接触は通常該溶液
中に所定Mのシリカゲルを加えて撹拌下に懸濁させるこ
とにより実施する。この接触は溶媒の蒸発を防止する観
点より溶媒の沸点より低い温度下で実施するとよい。
Ii [Q The contact between the lipid solution and the silica gel is usually carried out by adding a predetermined M of silica gel to the solution and suspending it under stirring. This contact is preferably carried out at a temperature lower than the boiling point of the solvent in order to prevent evaporation of the solvent.

本発明の方法によれば、上記の接触によりシリカゲルに
コレステロールを選択的に吸着させた後このシリカゲル
を例えばi濾過して除去し、次いで溶液から用いた非極
性溶媒を例えば減圧下で留去する。
According to the method of the invention, after the selective adsorption of cholesterol onto the silica gel by the above-mentioned contact, the silica gel is removed, e.g. by filtration, and the non-polar solvent used is then distilled off from the solution, e.g. under reduced pressure. .

このような本発明の方法によって得られた燐脂質はコレ
ステロール含世が通常約0.1%以下の精!ll燐脂質
であり、よってこのものの各種分野、とりわけ医薬の分
野での利用拡大が計れることが期待できる。
The phospholipids obtained by the method of the present invention usually have a cholesterol content of about 0.1% or less! It is a phospholipid, and therefore it can be expected to expand its use in various fields, especially in the pharmaceutical field.

〔発明の効果〕〔Effect of the invention〕

本発明の方法の効果を以下の試験例の結果でもって照明
する。
The effectiveness of the method of the invention is illustrated by the results of the following test examples.

墓呈1」− この試験例は、本発明の方法のコレステロール 。Grave presentation 1”- This test example uses cholesterol according to the method of the present invention.

除去効果が、適用される原料燐脂質に依り如何に異なる
かを示す。
It shows how the removal effect differs depending on the raw material phospholipid applied.

原料燐脂質: (1)精製卵黄燐脂質A (トリグリセリド1.0%、コレステロール2.0%、
燐脂質96.0%) (2)精製卵黄燐脂質B (トリグリセリド5.0%、コレステロール5.0%、
燐脂質90%) (3)粗製卵黄燐脂質A (トリグリセリド16%、コレステロール6.8%、燐
脂質75.0%) (4)粗製卵黄燐脂質B (トリグリセリド65%、コレステロール4.4%、燐
脂質30.0%) 上記各原料燐脂質について、原料燐脂質15gをn−ヘ
キサン100−に溶解さぜ、得られた溶液中に市販のカ
ラムクロマドグラフイー用シリカゲルを7.5g加えて
室温下で30分間撹拌したのち、シリカゲルを炉別し、
溶液からn−ヘキサンを減圧下で完全に留去させ、最終
燐脂質試料を得た。
Raw material phospholipids: (1) Purified egg yolk phospholipid A (triglyceride 1.0%, cholesterol 2.0%,
(phospholipid 96.0%) (2) Purified egg yolk phospholipid B (triglyceride 5.0%, cholesterol 5.0%,
phospholipid 90%) (3) Crude egg yolk phospholipid A (triglyceride 16%, cholesterol 6.8%, phospholipid 75.0%) (4) Crude egg yolk phospholipid B (triglyceride 65%, cholesterol 4.4%, (phospholipid 30.0%) For each of the above raw material phospholipids, dissolve 15 g of raw material phospholipid in 100% of n-hexane, add 7.5 g of commercially available silica gel for column chromatography to the resulting solution. After stirring at room temperature for 30 minutes, the silica gel was separated from the furnace.
The n-hexane was completely distilled off from the solution under reduced pressure to obtain the final phospholipid sample.

次いで各試料についてコレステロール残mをイヤトロス
キVンTH−10(lヤトロン社製)で調べた。その結
果を下記の表1に示す。
Next, each sample was examined for cholesterol residue using Iatroski V-Kin TH-10 (manufactured by Yatron). The results are shown in Table 1 below.

上記の結果から、トリグリセリド含量が約5%以下にま
で精製されている燐脂質原料でなければコレステロール
除去効果は奏し難いことがわかる。
From the above results, it can be seen that unless the phospholipid raw material is purified to a triglyceride content of about 5% or less, it is difficult to achieve the cholesterol removal effect.

試験例2 この試験例は、本発明の方法のコレステロール除去効果
が、用いる溶媒の種類に依り如何に異なるかを示す。
Test Example 2 This test example shows how the cholesterol removal effect of the method of the present invention varies depending on the type of solvent used.

精製卵黄燐脂質(トリグリセリド1.0%、コレステロ
ール2.0%、燐脂質96.0%)15Uを各々n−ペ
ンタン、n−ヘキサン、ジクロロメタンおよびエタノー
ル100m1!にそれぞれ溶解させ、得られた溶液中に
市販のa層りロマ1〜グラフィー用シリカゲルを15g
ずつ加えて室温下で30分間撹拌したのち、シリカゲル
を炉別し、各溶液からそれぞれ用いた溶媒を減圧下で完
全に留去させ、最終燐脂質試料を得た。
15 U of purified egg yolk phospholipid (triglyceride 1.0%, cholesterol 2.0%, phospholipid 96.0%) was added to 100 ml each of n-pentane, n-hexane, dichloromethane and ethanol! 15 g of commercially available a-layer Roma 1 to silica gel for graphics was dissolved in each of the solutions obtained.
After each solution was added and stirred at room temperature for 30 minutes, the silica gel was separated in a furnace, and the solvent used in each solution was completely distilled off under reduced pressure to obtain a final phospholipid sample.

次いで各試料についてコレステロール残はをイヤトロス
キャンTH−10で調べた。その結果を下記の表2に示
す。
Each sample was then examined for cholesterol residue using an Iatroscan TH-10. The results are shown in Table 2 below.

表    2 上記の結果から、非極性溶媒のみがコレステロール除去
効果をしたらし1ワることがわかる。
Table 2 From the above results, it can be seen that only the nonpolar solvent has a greater cholesterol removal effect.

〔実 施 例〕〔Example〕

以下、本発明を実施例でもって更に詳しく説明する。 Hereinafter, the present invention will be explained in more detail with reference to Examples.

実施例1 精製卵黄燐脂質(トリグリセリド0.1%、コレステロ
ール1.8%、燐脂質98.0%)120yをn−ヘキ
サン800m1に溶解させ、得られた溶液中に市販のa
層りロマ1−グラフィー用シリカゲルを12g加えてV
 4下で30分間撹拌したのち、シリカゲルを炉別し、
溶液からn−へキサンを減圧下で完全に留去させ、コレ
ステロール含量0.1%以下の精製卵黄燐脂質115j
を(!Vだ。
Example 1 120y of purified egg yolk phospholipid (triglyceride 0.1%, cholesterol 1.8%, phospholipid 98.0%) was dissolved in 800ml of n-hexane, and commercially available a
Add 12g of silica gel for layered Roma 1-graphy and V
After stirring for 30 minutes under
Completely distill n-hexane from the solution under reduced pressure to obtain purified egg yolk phospholipid 115j with a cholesterol content of 0.1% or less.
(!V.

実施例2 精製卵黄燐脂質(トリグリセリド0.5%、コレステロ
ール2.0%、燐脂質97.0%)150gをn−へブ
タン750dに溶解させ、得られた溶液中に市販のカラ
ムクロマトグラフィー用シリカゲル(予め130℃で3
時間活性化処理したもの)303を加えて室温下で1時
間撹拌したのち、シリカゲルをン戸別し、溶液からn−
へブタンを減圧下で完全に留去させ、コレステロール含
量0.1%以下の精製卵黄燐脂質143gを得た。
Example 2 150 g of purified egg yolk phospholipid (triglyceride 0.5%, cholesterol 2.0%, phospholipid 97.0%) was dissolved in 750 d of n-hebutane, and in the resulting solution, commercially available column chromatography grade Silica gel (pre-heated at 130°C)
After adding 303 (time-activated product) and stirring at room temperature for 1 hour, the silica gel was separated from the solution to n-
Hebutane was completely distilled off under reduced pressure to obtain 143 g of purified egg yolk phospholipid having a cholesterol content of 0.1% or less.

実施例3 牛の脳から選択抽出した粗製燐脂質をアゼトン処理して
精製燐脂質(トリグリセリド0.1%、コレステロール
2.0%、燐脂質95.0%)としたもの1007をn
−ヘキサン1000dに溶解させ、得られた溶液中にカ
ラムクロマトグラフィー用シリカゲル50yを加えて室
温下で30分間撹拌したのら、シリカゲルを?戸別し、
溶液からn−ヘキサンを減圧下で完全に留去さU、コレ
ステロール含ff10.1%以下の精″A燐脂質90び
を得た。
Example 3 Crude phospholipids selectively extracted from cow brain were treated with azetone to make purified phospholipids (triglyceride 0.1%, cholesterol 2.0%, phospholipids 95.0%) 1007
- Dissolved in 1000d of hexane, added 50y of silica gel for column chromatography to the resulting solution, stirred at room temperature for 30 minutes, and then dissolved the silica gel? going door to door,
N-hexane was completely distilled off from the solution under reduced pressure to obtain 90 purified A phospholipids having a cholesterol content of 10.1% or less.

Claims (1)

【特許請求の範囲】[Claims] コレステロールを含有せる精製燐脂質を非極性溶媒に溶
解させ、得られた溶液をシリカゲルに接触させた後この
シリカゲルを除去し、次いでこの溶液から上記非極性溶
媒を留去することを特徴とするコレステロールを実質上
含まない燐脂質の製法。
Cholesterol, characterized in that a purified phospholipid containing cholesterol is dissolved in a non-polar solvent, the resulting solution is brought into contact with silica gel, the silica gel is removed, and then the non-polar solvent is distilled off from this solution. A method for producing phospholipids that are substantially free of phospholipids.
JP17906385A 1985-08-14 1985-08-14 Rroduction of phospholipid containing substantially no cholesterol Pending JPS6239593A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP17906385A JPS6239593A (en) 1985-08-14 1985-08-14 Rroduction of phospholipid containing substantially no cholesterol

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP17906385A JPS6239593A (en) 1985-08-14 1985-08-14 Rroduction of phospholipid containing substantially no cholesterol

Publications (1)

Publication Number Publication Date
JPS6239593A true JPS6239593A (en) 1987-02-20

Family

ID=16059458

Family Applications (1)

Application Number Title Priority Date Filing Date
JP17906385A Pending JPS6239593A (en) 1985-08-14 1985-08-14 Rroduction of phospholipid containing substantially no cholesterol

Country Status (1)

Country Link
JP (1) JPS6239593A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011061995A1 (en) 2009-11-20 2011-05-26 キユーピー 株式会社 Process for production of purified egg-yolk phospholipid composition, and pharmaceutical composition, cosmetic composition or food composition comprising purified egg-yolk phospholipid composition produced by the process
WO2018042576A1 (en) * 2016-08-31 2018-03-08 キユーピー株式会社 Egg yolk phospholipid composition and method for producing same, and fat emulsion and lipolysis formulation using egg yolk phospholipid composition

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5942393A (en) * 1982-08-31 1984-03-08 Nippon Shinyaku Co Ltd Separation of phospholipid

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5942393A (en) * 1982-08-31 1984-03-08 Nippon Shinyaku Co Ltd Separation of phospholipid

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011061995A1 (en) 2009-11-20 2011-05-26 キユーピー 株式会社 Process for production of purified egg-yolk phospholipid composition, and pharmaceutical composition, cosmetic composition or food composition comprising purified egg-yolk phospholipid composition produced by the process
JP4723694B1 (en) * 2009-11-20 2011-07-13 キユーピー株式会社 Method for producing purified egg yolk phospholipid composition and pharmaceutical composition, cosmetic composition, or food composition using purified egg yolk phospholipid composition thus obtained
WO2018042576A1 (en) * 2016-08-31 2018-03-08 キユーピー株式会社 Egg yolk phospholipid composition and method for producing same, and fat emulsion and lipolysis formulation using egg yolk phospholipid composition

Similar Documents

Publication Publication Date Title
EP0415287B1 (en) Procedure for removing cholesterol and cholesterol esters from egg-yolk
CA1092148A (en) Purification process
JP5803671B2 (en) Method for reducing chloropropanols and their forming substances and glycidol fatty acid esters in glyceride oils and fats
DE60005241T2 (en) Process for the preparation of phosphatidylserines
JPH05153932A (en) Manufacture of antioxidisable spice extract
AU675116B2 (en) Method for extracting sphingomyelin from phospholipid con taining fat concentrate
JPH02153997A (en) Purification of fats and oils
JPH0228635B2 (en)
JP2900238B2 (en) Natural Menaquinone-7 High Lipid Content
JPH06306386A (en) Refining of fat or oil
JPS6239593A (en) Rroduction of phospholipid containing substantially no cholesterol
EP0054768A2 (en) A process for the separation of acylated phospholipids from phosphatidylcholin products containing them
DE3643848C2 (en)
EP0079799A1 (en) Fat refining
JPS59140299A (en) Manufacture of oil and fat containing high cholesterol quantity
DD265074A1 (en) PROCESS FOR OBTAINING COCOA BUTTERAROMA CONCENTRATE
JP2743178B2 (en) How to use adsorbent for lipid
DE1692567C3 (en) Process for the production of water-soluble and / or water-dispersible phosphatide emulsifiers
US2306776A (en) Process of treating vitaminiferous materials
US2360039A (en) Refining vitamin-containing
JPH01160989A (en) Production of docosahexanoyl phosphtatidylcholine
US20220411715A1 (en) Prevention of mcpd formation by auxiliary degumming
JPH0662648B2 (en) Method for producing high-purity lecithin
JP2640344B2 (en) A stable drug delivery base without skin irritation and acne performance
JPS6259287A (en) Production of phospholipid essentially free from lysophosphatidylcholine